israeli rezilion devsecops series guggenheim

Rezilion Secures $30 Million in Series A Fundin

Rezilion, a cyber startup that uses automation to transform DevSecOps, announced $30 million in Series A funding led by Guggenheim Investments. JVP and Kindred Capital contributed to the round, which also included new investment partners from Google, Microsoft, CrowdStrike, IBM, Cisco, PayPal, JP Morgan Chase, Nasdaq, eBay, Symantec, RedHat, RSA, and Tenable.

The pandemic has compelled more businesses to adopt and accelerate a digital-first approach to business, putting increased pressure on IT leaders and their development teams to deliver digital product experiences by critical deadlines. While DevOps has greatly accelerated code development, a problem has emerged between engineering and security teams. Understanding, mitigating, and controlling the risk that comes with these massive amounts of code still requires exhaustive manual work by highly skilled engineers. As a result, businesses must choose between remaining safe and releasing quickly.

The funds will be used to rapidly scale Rezilion’s go-to-market strategy, including partnering with other DevSecOps solution providers and expanding operations to serve customers in the United States and Europe. Additional product development aims to bridge the gap between security and engineering by increasing the productivity of both resources, allowing for the timely delivery of software and allowing organizations to innovate more quickly.

“At Rezilion, we are deeply committed to assisting organizations in driving their own innovation by reducing the resource drain, inaccuracies, and operational friction caused by manual security work,” said LiranTancman, Rezilion’s co-founder and CEO. “We believe there has never been a better time for organizations to experience ‘trust in motion,’ or the peace of mind that comes from moving quickly while remaining safe and secure.”

“Rezilion’s product suite is a game changer for security teams,” said Rusty Parks, Senior Managing Director of Guggenheim Investments. “It creates a win-win, allowing companies to speed innovative products and features to market while enhancing their security posture. We believe Rezilion has created a truly compelling value proposition for security teams, one that greatly increases return on time while thoroughly protecting one’s core infrastructure.”

About Rezilion

Rezilion is a leading autonomous DevSecOps platform that enables organizations to easily control and mitigate attack surfaces across cloud infrastructures, applications, and IoT devices from development to production. It significantly reduces the manual work that security and engineering teams must perform, bringing previously disparate efforts together and enabling organizations to innovate more quickly. Rezilion is rapidly attracting a growing client base of Fortune 100 companies and leading industry partners, with operations in Israel and the United States.

About Guggenheim Investments

Guggenheim Investments is Guggenheim Partners’ global asset management and investment advisory division, with over $255 billion* in total assets across fixed income, equity, and alternative strategies. They specialize in meeting the return and risk requirements of insurance companies, corporate and public pension funds, sovereign wealth funds, endowments and foundations, wealth managers, and high-net-worth investors.

Also search:

israeli rezilion devsecops series guggenheim
israeli rezilion series guggenheim
rezilion devsecops series guggenheim investmentslundentechcrunch
israeli rezilion devsecops series
rezilion devsecops series guggenheim
rezilion devsecops series guggenheim
rezilion series guggenheim investmentslundentechcrunch
rezilion devsecops 30m series guggenheim investmentslundentechcrunch
rezilion devsecops 30m guggenheim
rezilion devsecops 30m series investmentslundentechcrunch

Leave a Reply

Your email address will not be published. Required fields are marked *

madridbased 40m series capital Previous post Madrid’s ad platform Seedtag raises $40 million in series B funding
Next post Would Taking CBD Gummies Be A Wise Choice For Women Suffering With PCOS?